title: [Multidisciplinary guidelines for the management of community-acquired pneumonia].
abstract: Community-acquired pneumonia (CAP) is an infectious respiratory disease with an incidence that ranges from 3 to 8 cases per 1,000 inhabitants per year. This incidence increases with age and comorbidities. Forty per cent of CAP patients require hospitalization and around 10% of these patients are admitted in an Intensive Care Unit (ICU). Several studies have suggested that the implementation of clinical guidelines has a positive impact in the outcome of patients including mortality and length of stay. The more recent and used guidelines are those from Infectious Diseases Society of America/American Thoracic Society, published in 2007, the 2009 from the British Thoracic Society, and that from the European Respiratory Society/European Society of Clinical Microbiology and Infectious Diseases, published in 2010. In Spain, the most recently released guideline is the Sociedad Española de Neumología y Cirugía Torácica-2011 guideline. The present guidelines GNAC are designed to be used by the majority of health-care professionals that can participate in the care of CAP patients including diagnosis, decision of hospital and ICU admission, treatment and prevention. The Centro Cochrane Iberoamericano (CCIB) has participated in summarizing the previous guidelines and in the bibliography search. For each one of the following sections the panel of experts has developed a table with recommendations classified according to its evidence, strength and practical applicability using the Grading of Recommendations of Assessment Development and Evaluations (GRADE) system: 1. Epidemiology, microbiological etiology and antibiotic resistances.2. Clinical and microbiological diagnosis.3. Prognostic scales and decision of hospital admission.4. ICU admission criteria. 5. Empirical and definitive antibiotic treatment.6. Treatment failure. 7. Prevention.
authors.forename: Antoni
authors.initials: A
authors.lastname: Torres
authors.forename: José
authors.initials: J
authors.lastname: Barberán
authors.forename: Miquel
authors.initials: M
authors.lastname: Falguera
authors.forename: Rosario
authors.initials: R
authors.lastname: Menéndez
authors.forename: Jesús
authors.initials: J
authors.lastname: Molina
authors.forename: Pedro
authors.initials: P
authors.lastname: Olaechea
authors.forename: Alejandro
authors.initials: A
authors.lastname: Rodríguez
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000628:therapy; D006760:Hospitalization; D006801:Humans; D007362:Intensive Care Units; D011014:Pneumonia / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy*; D011379:Prognosis; D014611:Vaccination
chemical_list: D000900:Anti-Bacterial Agents